Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclophilin B (CypB) is a peptidyl-prolyl cis-trans isomerase (PPIase) that catalyzes the isomerization of proline residues in proteins, facilitating protein folding. It plays a crucial role in protein folding within the endoplasmic reticulum (ER) and is involved in various cellular processes, including transcriptional regulation and cytokine-like signaling. CypB's involvement in inflammatory diseases, viral infections (like HCV replication), and cancer progression makes it a potential therapeutic target. It interacts with drugs like cyclosporine A, which has clinical significance due to immunosuppressive properties.
Inhibition of PPIase activity; modulation of protein folding and signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase B (CypB).